Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE690.8052.35 (+8.2 %)

PREV CLOSE ( ) 638.45

OPEN PRICE ( ) 642.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 74348

TODAY'S LOW / HIGH ( )613.00 698.00

52 WK LOW / HIGH ( )265 698

NSE689.1550.65 (+7.93 %)

PREV CLOSE( ) 638.50

OPEN PRICE ( ) 636.95

BID PRICE (QTY) 689.15 (122)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 917161

TODAY'S LOW / HIGH( ) 611.00 699.00

52 WK LOW / HIGH ( )263.3 699

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

-1038.65

582.16

896.85

1188.20

360.60

Adjustment

1704.40

558.86

314.72

244.82

155.44

Changes In working Capital

385.06

-1247.59

-1108.40

-640.92

-219.08

Cash Flow after changes in Working Capital

1050.80

-106.56

103.17

792.10

296.97

Cash Flow from Operating Activities

922.94

-221.93

6.86

435.58

205.75

Cash Flow from Investing Activities

-112.45

-934.27

-747.98

-1089.33

-275.60

Cash Flow from Financing Activities

-965.96

1313.65

618.46

754.57

32.82

Net Cash Inflow / Outflow

-155.46

157.45

-122.66

100.83

-37.03

Opening Cash & Cash Equivalents

177.20

19.75

142.41

41.59

78.62

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

21.75

177.20

19.75

142.41

41.59